为了比较三种技术在减少埃托米达特诱导的肌细胞瘤的疗效 - 一个随机对照试验
Ridhi Rao1, Geetha Rajappa2, B K Sandhya2
1Department of Anaesthesiology, Indira Gandhi Institute of Child Health, Bengaluru, Karnataka, India.
Indian journal of anaesthesia
|March 31, 2025
概括
预防埃托米达诱导肌细胞瘤 (EIM) 是至关重要的. 在一项随机研究中,原始化和缓慢注射技术的组合在减少EIM发生率和严重程度方面被证明是最有效的.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
背景情况:
- 埃托米达是血液动力学不稳定的患者的首选诱导剂.
- 埃托米达诱导的肌 (EIM) 是一种常见的副作用,需要采取预防策略.
研究的目的:
- 为了比较三种埃托米达施用技术在预防EIM方面的疗效.
- 评估原始化,缓慢注射和联合技术对EIM发病率和严重性的影响.
主要方法:
- 一项随机对照研究涉及296名接受全身麻醉的患者.
- 患者通过控制,原始化,缓慢注射或组合原始化和缓慢注射技术接受埃托米达.
- 记录了肌细胞瘤的发生率,发病和程度,以及注射时的疼痛和血液动力学参数.
主要成果:
- 与对照组 (73.0%,P=0.001) 相比,组合的原始化和缓慢注射技术显著降低了EIM发生率 (37.8%).
- 这种结合的技术在预防EIM和降低肌细胞结核强度方面最有效.
- 在组合组中,3级肌细胞结核明显较低 (6.76%) 与对照组 (52.7%,P=0.0001) 相比.
结论:
- 原始化和缓慢注射技术单独显示出在减少EIM方面的有效性.
- 化和缓慢的埃托米达注射的组合是预防EIM的最有效策略.
更多相关视频
相关概念视频
Skeletal Muscle Relaxants: Adverse Effects
316
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
316
Skeletal Muscle Relaxants: Therapeutic Uses
443
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
443
Electroconvulsive Therapy
19
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
19
Parenteral Anesthetics: Overview
87
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
87
Sedatives and Hypnotics Drugs: Miscellaneous Agents
132
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
132
Depolarizing Blockers: Pharmocokinetics
296
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
296


